Thackray Helen M. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$175,800.00
Insider Sells Quantity
12
Insider Sells Sum
$833,970.93

Insider Activity of Thackray Helen M.

Biography of Thackray Helen M.

No biography is available at this moment.

2024-05-14PurchaseBioCryst Pharmaceuticals, Inc.
BCRX
Chief R&D Officer
30,000
0.0159%
$5.86$175,800+42.26%
2023-04-03SaleBioCryst Pharmaceuticals, Inc.
BCRX
Chief R&D Officer
7,000
0.0037%
$8.29$58,030-18.28%
2022-12-15SaleBioCryst Pharmaceuticals, Inc.
BCRX
Chief R&D Officer
3,125
0.0018%
$10.89$34,031-30.43%
2022-04-01SaleBioCryst Pharmaceuticals, Inc.
BCRX
Chief R&D Officer
7,600
0.004%
$16.20$123,120-34.09%
2017-12-08SaleCrescent Biopharma, Inc.
CBIO
SVP Clinical Development, CMO
2,000
0.1163%
$15.01$30,020+8.82%
2017-09-18SaleCrescent Biopharma, Inc.
CBIO
SVP Clinical Development, CMO
2,000
0.1471%
$13.00$26,000+16.14%
2017-05-25SaleCrescent Biopharma, Inc.
CBIO
SVP Clinical Development, CMO
2,000
0.2013%
$15.57$31,140+1.58%
2017-05-19SaleCrescent Biopharma, Inc.
CBIO
SVP Clinical Development, CMO
2,000
0.1554%
$12.14$24,280+9.64%
2016-10-03SaleCrescent Biopharma, Inc.
CBIO
VP Clinical Development, CMO
4,000
0.2031%
$7.00$28,001-5.15%
2016-07-20SaleCrescent Biopharma, Inc.
CBIO
VP Clinical Development, CMO
2,000
0.1023%
$8.00$16,000-20.49%
2016-07-06SaleCrescent Biopharma, Inc.
CBIO
VP Clinical Development, CMO
6,796
0.2572%
$6.68$45,397-3.74%
2016-07-05SaleCrescent Biopharma, Inc.
CBIO
VP Clinical Development, CMO
10,136
0.392%
$7.01$71,053-5.85%
2016-07-01SaleCrescent Biopharma, Inc.
CBIO
VP Clinical Development, CMO
5,068
0.2069%
$7.40$37,503-14.38%
Total: 13
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.